Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Eric Freed
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Living Beings
Chemicals & Drugs
Physiology
Anatomy
Genes & Molecular Sequences
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
19
Ono, Akira
14
Nagashima, Kunio
13
Ablan, Sherimay
9
Adamson, Catherine
8
Demirov, Dimiter
8
Waheed, Abdul
8
Martin, Malcolm
5
Salzwedel, Karl
5
Orenstein, Jan
3
Pathak, Vinay
3
Kiernan, RE
3
Levin, Judith
3
Li, Feng
3
Fisher, Robert
3
Goila-Gaur, Ritu
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Eric Freed (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Bennett Adam E; Narayan Kedar; Shi Dan; Hartnell Lisa M; Gousset Karine; He Haifeng; Lowekamp Bradley C; Yoo Terry S; Bliss Donald; Freed Eric O; Subramaniam Sriram
Ion-abrasion scanning electron microscopy reveals surface-connected tubular conduits in HIV-infected macrophages.
PLoS pathogens 2009;5(9):e1000591.
-
2009: Fujii Ken; Munshi Utpal M; Ablan Sherimay D; Demirov Dimiter G; Soheilian Ferri; Nagashima Kunio; Stephen Andrew G; Fisher Robert J; Freed Eric O
Functional role of Alix in HIV-1 replication.
Virology 2009;391(2):284-92.
-
2009: Adamson Catherine S; Salzwedel Karl; Freed Eric O
Virus maturation as a new HIV-1 therapeutic target.
Expert opinion on therapeutic targets 2009;13(8):895-908.
-
2009: Waheed Abdul A; Freed Eric O
Lipids and membrane microdomains in HIV-1 replication.
Virus research 2009;143(2):162-76.
-
2009: Joshi Anjali; Ablan Sherimay D; Soheilian Ferri; Nagashima Kunio; Freed Eric O
Evidence that productive human immunodeficiency virus type 1 assembly can occur in an intracellular compartment.
Journal of virology 2009;83(11):5375-87.
-
2009: Adamson Catherine S; Waki Kayoko; Ablan Sherimay D; Salzwedel Karl; Freed Eric O
Impact of human immunodeficiency virus type 1 resistance to protease inhibitors on evolution of resistance to the maturation inhibitor bevirimat (PA-457).
Journal of virology 2009;83(10):4884-94.
-
2009: Adamson Catherine S; Freed Eric O
Anti-HIV-1 therapeutics: from FDA-approved drugs to hypothetical future targets.
Molecular interventions 2009;9(2):70-4.
-
2009: Joshi Anjali; Nagashima Kunio; Freed Eric O
Defects in cellular sorting and retroviral assembly induced by GGA overexpression.
BMC cell biology 2009;10():72.
-
2009: Waheed Abdul A; Ono Akira; Freed Eric O
Methods for the study of HIV-1 assembly.
Methods in molecular biology (Clifton, N.J.) 2009;485():163-84.
-
2008: Joshi Anjali; Munshi Utpal; Ablan Sherimay D; Nagashima Kunio; Freed Eric O
Functional replacement of a retroviral late domain by ubiquitin fusion.
Traffic (Copenhagen, Denmark) 2008;9(11):1972-83.
-
2008: Waheed Abdul A; Ablan Sherimay D; Soheilian Ferri; Nagashima Kunio; Ono Akira; Schaffner Carl P; Freed Eric O
Inhibition of human immunodeficiency virus type 1 assembly and release by the cholesterol-binding compound amphotericin B methyl ester: evidence for Vpu dependence.
Journal of virology 2008;82(19):9776-81.
-
2008: Adamson Catherine S; Freed Eric O
Recent progress in antiretrovirals--lessons from resistance.
Drug discovery today 2008;13(9-10):424-32.
-
2008: Joshi Anjali; Garg Himanshu; Nagashima Kunio; Bonifacino Juan S; Freed Eric O
GGA and Arf proteins modulate retrovirus assembly and release.
Molecular cell 2008;30(2):227-38.
-
2008: Gousset Karine; Ablan Sherimay D; Coren Lori V; Ono Akira; Soheilian Ferri; Nagashima Kunio; Ott David E; Freed Eric O
Real-time visualization of HIV-1 GAG trafficking in infected macrophages.
PLoS pathogens 2008;4(3):e1000015.
-
2008: Luttge Benjamin G; Shehu-Xhilaga Miranda; Demirov Dimiter G; Adamson Catherine S; Soheilian Ferri; Nagashima Kunio; Stephen Andrew G; Fisher Robert J; Freed Eric O
Molecular characterization of feline immunodeficiency virus budding.
Journal of virology 2008;82(5):2106-19.
-
2007: Fujii Ken; Hurley James H; Freed Eric O
Beyond Tsg101: the role of Alix in 'ESCRTing' HIV-1.
Nature reviews. Microbiology 2007;5(12):912-6.
-
2007: Waheed Abdul A; Freed Eric O
Influenza virus not cRAFTy enough to dodge viperin.
Cell host & microbe 2007;2(2):71-2.
-
2007: Waheed Abdul A; Ablan Sherimay D; Roser James D; Sowder Raymond C; Schaffner Carl P; Chertova Elena; Freed Eric O
HIV-1 escape from the entry-inhibiting effects of a cholesterol-binding compound via cleavage of gp41 by the viral protease.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(20):8467-71.
-
2007: Ono Akira; Waheed Abdul A; Freed Eric O
Depletion of cellular cholesterol inhibits membrane binding and higher-order multimerization of human immunodeficiency virus type 1 Gag.
Virology 2007;360(1):27-35.
-
2007: Tang Shixing; Ablan Sherimay; Dueck Megan; Ayala-López Wilfredo; Soto Brenda; Caplan Margaret; Nagashima Kunio; Hewlett Indira K; Freed Eric O; Levin Judith G
A second-site suppressor significantly improves the defective phenotype imposed by mutation of an aromatic residue in the N-terminal domain of the HIV-1 capsid protein.
Virology 2007;359(1):105-15.
-
2007: Munshi Utpal M; Kim Jaewon; Nagashima Kunio; Hurley James H; Freed Eric O
An Alix fragment potently inhibits HIV-1 budding: characterization of binding to retroviral YPXL late domains.
The Journal of biological chemistry 2007;282(6):3847-55.
-
2007: Adamson Catherine S; Freed Eric O
Human immunodeficiency virus type 1 assembly, release, and maturation.
Advances in pharmacology (San Diego, Calif.) 2007;55():347-87.
-
2006: Li Feng; Zoumplis Dorian; Matallana Claudia; Kilgore Nicole R; Reddick Mary; Yunus Abdul S; Adamson Catherine S; Salzwedel Karl; Martin David E; Allaway Graham P; Freed Eric O; Wild Carl T
Determinants of activity of the HIV-1 maturation inhibitor PA-457.
Virology 2006;356(1-2):217-24.
-
2006: Adamson Catherine S; Ablan Sherimay D; Boeras Ioana; Goila-Gaur Ritu; Soheilian Ferri; Nagashima Kunio; Li Feng; Salzwedel Karl; Sakalian Michael; Wild Carl T; Freed Eric O
In vitro resistance to the human immunodeficiency virus type 1 maturation inhibitor PA-457 (Bevirimat).
Journal of virology 2006;80(22):10957-71.
-
2006: Liu Fa; Stephen Andrew G; Adamson Catherine S; Gousset Karine; Aman M Javad; Freed Eric O; Fisher Robert J; Burke Terrence R
Hydrazone- and hydrazide-containing N-substituted glycines as peptoid surrogates for expedited library synthesis: application to the preparation of Tsg101-directed HIV-1 budding antagonists.
Organic letters 2006;8(22):5165-8.
-
2006: Waheed Abdul A; Ablan Sherimay D; Mankowski Marie K; Cummins James E; Ptak Roger G; Schaffner Carl P; Freed Eric O
Inhibition of HIV-1 replication by amphotericin B methyl ester: selection for resistant variants.
The Journal of biological chemistry 2006;281(39):28699-711.
-
2006: Joshi Anjali; Nagashima Kunio; Freed Eric O
Mutation of dileucine-like motifs in the human immunodeficiency virus type 1 capsid disrupts virus assembly, gag-gag interactions, gag-membrane binding, and virion maturation.
Journal of virology 2006;80(16):7939-51.
-
2006: Freed Eric O
HIV-1 Gag: flipped out for PI(4,5)P(2).
Proceedings of the National Academy of Sciences of the United States of America 2006;103(30):11101-2.
-
2006: Fu William; Dang Que; Nagashima Kunio; Freed Eric O; Pathak Vinay K; Hu Wei-Shau
Effects of Gag mutation and processing on retroviral dimeric RNA maturation.
Journal of virology 2006;80(3):1242-9.
-
2006: Freed Eric O; Mouland Andrew J
The cell biology of HIV-1 and other retroviruses.
Retrovirology 2006;3():77.
-
2005: Ono Akira; Waheed Abdul A; Joshi Anjali; Freed Eric O
Association of human immunodeficiency virus type 1 gag with membrane does not require highly basic sequences in the nucleocapsid: use of a novel Gag multimerization assay.
Journal of virology 2005;79(22):14131-40.
-
2005: Sklar Peter A; Masur Henry; Grubb Jessica R; Voell Jocelyn; Witek James; Ono Akira; Freed Eric O; Maldarelli Frank
Pravastatin does not have a consistent antiviral effect in chronically HIV-infected individuals on antiretroviral therapy.
AIDS (London, England) 2005;19(10):1109-11.
-
2005: Ono Akira; Freed Eric O
Role of lipid rafts in virus replication.
Advances in virus research 2005;64():311-58.
-
2004: Demirov Dimiter G; Freed Eric O
Retrovirus budding.
Virus research 2004;106(2):87-102.
-
2004: Freed Eric O
Mechanisms of enveloped virus release.
Virus research 2004;106(2):85-6.
-
2004: Ono Akira; Ablan Sherimay D; Lockett Stephen J; Nagashima Kunio; Freed Eric O
Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(41):14889-94.
-
2004: Svarovskaia Evguenia S; Xu Hongzhan; Mbisa Jean L; Barr Rebekah; Gorelick Robert J; Ono Akira; Freed Eric O; Hu Wei-Shau; Pathak Vinay K
Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs.
The Journal of biological chemistry 2004;279(34):35822-8.
-
2004: Freed Eric O
HIV-1 and the host cell: an intimate association.
Trends in microbiology 2004;12(4):170-7.
-
2004: Ono Akira; Freed Eric O
Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body.
Journal of virology 2004;78(3):1552-63.
-
2004: Murakami Tsutomu; Ablan Sherimay; Freed Eric O; Tanaka Yuetsu
Regulation of human immunodeficiency virus type 1 Env-mediated membrane fusion by viral protease activity.
Journal of virology 2004;78(2):1026-31.
-
2004: Shehu-Xhilaga Miranda; Ablan Sherimay; Demirov Dimiter G; Chen Chaoping; Montelaro Ronald C; Freed Eric O
Late domain-dependent inhibition of equine infectious anemia virus budding.
Journal of virology 2004;78(2):724-32.
-
2004: Freed Eric O; Ross Susan R
Retroviruses 2004: review of the 2004 Cold Spring Harbor Retroviruses Conference.
Retrovirology 2004;1():25.
-
2003: Tang Shixing; Murakami Tsutomu; Cheng Naiqian; Steven Alasdair C; Freed Eric O; Levin Judith G
Human immunodeficiency virus type 1 N-terminal capsid mutants containing cores with abnormally high levels of capsid protein and virtually no reverse transcriptase.
Journal of virology 2003;77(23):12592-602.
-
2003: Li F; Goila-Gaur R; Salzwedel K; Kilgore N R; Reddick M; Matallana C; Castillo A; Zoumplis D; Martin D E; Orenstein J M; Allaway G P; Freed E O; Wild C T
PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(23):13555-60.
-
2003: Goila-Gaur Ritu; Demirov Dimiter G; Orenstein Jan M; Ono Akira; Freed Eric O
Defects in human immunodeficiency virus budding and endosomal sorting induced by TSG101 overexpression.
Journal of virology 2003;77(11):6507-19.
-
2003: Freed Eric O
The HIV-TSG101 interface: recent advances in a budding field.
Trends in microbiology 2003;11(2):56-9.
-
2002: Freed Eric O
Viral late domains.
Journal of virology 2002;76(10):4679-87.
-
2002: Freed Eric O
Virology. Rafting with Ebola.
Science (New York, N.Y.) 2002;296(5566):279.
-
2002: Demirov Dimiter G; Ono Akira; Orenstein Jan M; Freed Eric O
Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(2):955-60.
-
2002: Demirov Dimiter G; Orenstein Jan M; Freed Eric O
The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner.
Journal of virology 2002;76(1):105-17.
-
2001: Ono A; Freed E O
Plasma membrane rafts play a critical role in HIV-1 assembly and release.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(24):13925-30.
-
2001: Tang S; Murakami T; Agresta B E; Campbell S; Freed E O; Levin J G
Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells.
Journal of virology 2001;75(19):9357-66.
-
2000: Halvas E K; Svarovskaia E S; Freed E O; Pathak V K
Wild-type and YMDD mutant murine leukemia virus reverse transcriptases are resistant to 2',3'-dideoxy-3'-thiacytidine.
Journal of virology 2000;74(14):6669-74.
-
2000: Ono A; Demirov D; Freed E O
Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding.
Journal of virology 2000;74(11):5142-50.
-
2000: Murakami T; Freed E O
Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail.
Journal of virology 2000;74(8):3548-54.
-
2000: Ono A; Orenstein J M; Freed E O
Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly.
Journal of virology 2000;74(6):2855-66.
-
2000: Murakami T; Freed E O
The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(1):343-8.
-
1999: Kiernan R E; Ono A; Freed E O
Reversion of a human immunodeficiency virus type 1 matrix mutation affecting Gag membrane binding, endogenous reverse transcriptase activity, and virus infectivity.
Journal of virology 1999;73(6):4728-37.
-
1999: Ono A; Freed E O
Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus.
Journal of virology 1999;73(5):4136-44.
-
1998: Kiernan R E; Freed E O
Cleavage of the murine leukemia virus transmembrane env protein by human immunodeficiency virus type 1 protease: transdominant inhibition by matrix mutations.
Journal of virology 1998;72(12):9621-7.
-
1998: Kiernan R E; Ono A; Englund G; Freed E O
Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle.
Journal of virology 1998;72(5):4116-26.
-
1997: Ono A; Huang M; Freed E O
Characterization of human immunodeficiency virus type 1 matrix revertants: effects on virus assembly, Gag processing, and Env incorporation into virions.
Journal of virology 1997;71(6):4409-18.
-
1997: Freed E O; Englund G; Maldarelli F; Martin M A
Phosphorylation of residue 131 of HIV-1 matrix is not required for macrophage infection.
Cell 1997;88(2):171-3; discussion 173-4.
-
1996: Willey R L; Shibata R; Freed E O; Cho M W; Martin M A
Differential glycosylation, virion incorporation, and sensitivity to neutralizing antibodies of human immunodeficiency virus type 1 envelope produced from infected primary T-lymphocyte and macrophage cultures.
Journal of virology 1996;70(9):6431-6.
-
1996: Freed E O; Martin M A
Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions.
Journal of virology 1996;70(1):341-51.
-
1995: Huang M; Orenstein J M; Martin M A; Freed E O
p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease.
Journal of virology 1995;69(11):6810-8.
-
1995: Freed E O; Englund G; Martin M A
Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection.
Journal of virology 1995;69(6):3949-54.
-
1995: Englund G; Theodore T S; Freed E O; Engelman A; Martin M A
Integration is required for productive infection of monocyte-derived macrophages by human immunodeficiency virus type 1.
Journal of virology 1995;69(5):3216-9.
-
1995: Freed E O; Martin M A
Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix.
Journal of virology 1995;69(3):1984-9.
-
1994: Freed E O; Orenstein J M; Buckler-White A J; Martin M A
Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production.
Journal of virology 1994;68(8):5311-20.
Sign-in to see more
